Antimicrobial Susceptibility Testing Market, by Product Type (Manual Antimicrobial Susceptibility Testing Products (Susceptibility Testing Disks, Mic Strips and Susceptibility Plates), Automated Laboratory Instruments and Consumables), by Application (Antibacterial, Antifungal, Anti-parasitic, and Antiviral), by Method (Disk Diffusion, Rapid Automated AST, Broth Dilution, Gradient Diffusion, and Genotypic Methods) by Distribution Channel (Hospitals, Pathology/Diagnostic Laboratories, Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
Antimicrobial susceptibility testing (AST) confirms susceptibility, detects resistance, and guides the selection of patient therapy. The tests can guide the physician in drug choice and dosage for difficult-to-treat infections. Antibiotic resistance is a major global health concern which requires action across the globe. It is increased due to antibiotic misuse and has become a major global health concern. Current methods for antimicrobial susceptibility testing (AST) used to probe for resistant or nonresistant (susceptible) phenotypes of pathogens, typically requires between two days to one week from the time of sample collection.
Market Dynamics
The rising incidence of infectious diseases is expected to drive the global antimicrobial susceptibility testing market growth over the forecast period.
For instance, according to the World Health Organization (WHO) Fact Sheet published in October 2021, a total of 1.5 million people died from tuberculosis (TB) in 2020 (including 214,000 people with HIV) globally.
According to the same source, TB is the world’s 13th leading cause of death and the second leading infectious killer after COVID-19.
Moreover, antimicrobial susceptibility testing market is expected to witness significant growth owing to increasing launches of product by key player. For instance in 2019, F.Hoffmann-La Roche Ltd., a research-based healthcare company announced the CE-IVD launch of the cobas MTB-RIF/INH test to detect resistance to antibiotics with in tuberculosis DNA
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook